[1] MARTINS JP, ANDONIOU CE, FLEMING P, et al. Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation. Science. 2019;363(6424):288-293.
[2] ZHAN Y, WANG L, LIU G, et al. The Reparative Effects of Human Adipose-Derived Mesenchymal Stem Cells in the Chemotherapy-Damaged Thymus. Stem Cells Dev. 2019;28(3):186-195.
[3] DE LUCA L, TRINO S, LAURENZANA I, et al. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation? Int J Mol Sci. 2017;18(5):1022.
[4] ROH KH, ROY K. Engineering approaches for regeneration of T lymphopoiesis. Biomater Res. 2016;20:20.
[5] DUINHOUWER LE, BEIJE N, VAN DER HOLT B, et al. Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation. Bone Marrow Transplant. 2018; 53(6):673-682.
[6] DA ROCHA LKA, FRESCHI DE BARROS S, BANDEIRA F, et al. Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation. Front Immunol. 2018;9:1889.
[7] FAHY GM, BROOKE RT, WATSON JP, et al. Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell. 2019;18(6):e13028.
[8] CHAUDHRY MS, VELARDI E, DUDAKOV JA, et al. Thymus: the next (re)generation. Immunol Rev. 2016;271(1):56-71.
[9] LI L, SHANG L, GAO J, et al. Janus kinase inhibitor ruxolitinib blocks thymic regeneration after acute thymus injury. Biochem Pharmacol. 2020;171:113712.
[10] KUMMOLA L, ORTUTAY Z, CHEN X, et al. IL-7Ralpha Expression Regulates Murine Dendritic Cell Sensitivity to Thymic Stromal Lymphopoietin. J Immunol. 2017;198(10):3909-3918.
[11] OGONEK J, VARANASI P, LUTHER S, et al. Possible Impact of Cytomegalovirus-Specific CD8+ T Cells on Immune Reconstitution and Conversion to Complete Donor Chimerism after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2017;23(7):1046-1053.
[12] KAEUFERLE T, KRAUSS R, BLAESCHKE F, et al. Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation. J Hematol Oncol. 2019;12(1):13.
[13] ZHAO XY, PEI XY, CHANG YJ, et al. First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)-specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation. Clin Infect Dis. 2020;70(7):1429-1437.
[14] OGONEK J, VERMA K, SCHULTZE-FLOREY C, et al. Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation. J Immunol. 2017;199(2):792-805.
[15] REDDEHASE MJ. Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation. Front Immunol. 2016;7:294.
[16] GABEL M, BAUMANN NS, OXENIUS A, et al. Investigating the Dynamics of MCMV-Specific CD8+ T Cell Responses in Individual Hosts. Front Immunol. 2019;10:1358.
[17] STYCZYNSKI J. Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation. Infect Dis Ther. 2018;7(1):1-16.
[18] CRIPPA S, SANTI L, BOSOTTI R, et al. Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders. J Clin Med. 2019;9(1):2.
[19] ARJMAND B, GOODARZI P, AGHAYAN HR, et al. Co-transplantation of Human Fetal Mesenchymal and Hematopoietic Stem Cells in Type 1 Diabetic Mice Model. Front Endocrinol (Lausanne). 2019;10:761.
[20] YI J, CHEN Z, XU F, et al. IL-27 Promotes Human Placenta-Derived Mesenchymal Stromal Cell Ability To Induce the Generation of CD4+IL-10+IFN-γ+ T Cells via the JAK/STAT Pathway in the Treatment of Experimental Graft-versus-Host Disease. J Immunol. 2019;202(4):1124-1136.
[21] LIM JY, RYU DB, LEE SE, et al. Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model. J Invest Dermatol. 2017;137(9):1895-1904.
[22] LAI P, CHEN X, GUO L, et al. A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD. J Hematol Oncol. 2018;11(1):135.
[23] FANG S, XU C, ZHANG Y, et al. Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing. Stem Cells Transl Med. 2016; 5(10):1425-1439.
[24] CHENG X, ZHANG G, ZHANG L, et al. Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration. J Cell Mol Med. 2018;22(1):261-276.
[25] LUTHER KM, HAAR L, MCGUINNESS M, et al. Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells. J Mol Cell Cardiol. 2018;119:125-137.
[26] LI JW, WEI L, HAN Z, et al. Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p. Eur J Pharmacol. 2019;852:68-76.
[27] ZENG YL, ZHENG H, CHEN QR, et al. Bone marrow-derived mesenchymal stem cells overexpressing MiR-21 efficiently repair myocardial damage in rats. Oncotarget. 2017;8(17):29161-29173.
[28] FENG Z, CHEN H, FU T, et al. miR-21 modification enhances the performance of adipose tissue-derived mesenchymal stem cells for counteracting urethral stricture formation. J Cell Mol Med. 2018; 22(11):5607-5616.
[29] ZHOU Y, ZHU Y, ZHANG L, et al. Human Stem Cells Overexpressing miR-21 Promote Angiogenesis in Critical Limb Ischemia by Targeting CHIP to Enhance HIF-1α Activity. Stem Cells. 2016;34(4):924-934.
[30] LI CX, TALELE NP, BOO S, et al. MicroRNA-21 preserves the fibrotic mechanical memory of mesenchymal stem cells. Nat Mater. 2017; 16(3):379-389.
[31] AN X, MA K, ZHANG Z, et al. miR-17, miR-21, and miR-143 Enhance Adipogenic Differentiation from Porcine Bone Marrow-Derived Mesenchymal Stem Cells. DNA Cell Biol. 2016;35(8):410-416.
[32] CHO JW, SEO MS, KANG KK, et al. Effect of human thymus adipose tissue-derived mesenchymal stem cells on myocardial infarction in rat model. Regen Ther. 2019;11:192-198.
[33] ZHANG X, TU H, YANG Y, et al. Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway. J Biol Chem. 2019; 294(32):12167-12179.
[34] CHANDRA PK, GERLACH SL, WU C, et al. Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NFκB signaling pathway. Sci Rep. 2018;8(1):14702.
[35] LIN BL, CHEN JF, QIU WH, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: A randomized controlled trial. Hepatology. 2017; 66(1):209-219.
[36] KHATRI M, RICHARDSON LA, MEULIA T. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model. Stem Cell Res Ther. 2018;9(1):17.
[37] LOY H, KUOK DIT, HUI KPY, et al. Therapeutic Implications of Human Umbilical Cord Mesenchymal Stromal Cells in Attenuating Influenza A(H5N1) Virus-Associated Acute Lung Injury. J Infect Dis. 2019;219(2): 186-196.
[38] LOPES-PACHECO M, ROBBA C, ROCCO PRM, et al. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome. Cell Biol Toxicol. 2020;36(1):83-102.
[39] URBANEK K, DE ANGELIS A, SPAZIANO G, et al. Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model. PLoS One. 2016;11(7):e0158746.
[40] AN SY, JANG YJ, LIM HJ, et al. Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice. Gastroenterology. 2017;152(5):1174-1186.
[41] WILLIS GR, FERNANDEZ-GONZALEZ A, ANASTAS J, et al. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation. Am J Respir Crit Care Med. 2018;197(1):104-116.
[42] JAFRI MA, KALAMEGAM G, ABBAS M, et al. Deciphering the Association of Cytokines, Chemokines, and Growth Factors in Chondrogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells Using an ex vivo Osteochondral Culture System. Front Cell Dev Biol. 2020;7: 380.
[43] QI K, LI N, ZHANG Z, et al. Tissue regeneration: The crosstalk between mesenchymal stem cells and immune response. Cell Immunol. 2018; 326:86-93.
[44] HONG J, HUECKELHOVEN A, WANG L, et al. Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8(+) T cell proliferation by human mesenchymal stromal cells. Cytotherapy. 2016; 18(5):621-629.
[45] KADLE RL, ABDOU SA, VILLARREAL-PONCE AP, et al. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion. PLoS One. 2018;13(3):e0193178.
[46] ZHU H, LAN L, ZHANG Y, et al. Epidermal growth factor stimulates exosomal microRNA-21 derived from mesenchymal stem cells to ameliorate aGVHD by modulating regulatory T cells. FASEB J. 2020; 34(6):7372-7386.
|